Sorin is now LivaNova. Learn more here

The Company

At the heart of medical technology

Sorin Group’s products improve health and the quality of life of more than 1 million patients in 100 countries every year.

To deliver on our commitments to patients and healthcare providers, Sorin Group teams continue to research, develop, and deliver reliable and state-of-the-art therapeutic solutions that address unmet cardiovascular needs and improve patient outcomes.   

At Sorin Group, we are proud that our products help people all over the world live better day after day.

Our Core Therapeutic Areas


As a world leader in cardiac surgery, we provide you with a wide range of innovative therapeutic solutions for both open heart and minimally-invasive cardiac surgery (MICS).  Learn more.

Please note that Sutureless Valves are not available for sale or distribution in the USA

Cardiac Rhythm Management

As a major global player in cardiac rhythm management, our portfolio offers innovative options that address the needs of patients and healthcare professionals: from implantable cardiac defibrillators and pacemakers to systems for cardiac resynchronization therapy (CRT), patient management, and arrhythmia assessment. Learn more.

Improving patient care through Innovation

We are committed to delivering innovative solutions to patients that will extend and improve their lives.

Through our close collaboration between Sorin Group engineers and cardiology experts at leading universities and research centers worldwide, we continuously learn about the needs of both clinicians and patients.

Based on these insights, we continue to extend our leading portfolio of products for the treatment of cardiovascular diseases.   

To ensure better patient outcomes around the globe, we organize state-of-the-art education and training programs where we introduce our new therapeutic solutions and provide guidance on their use. 

Expanding access to therapeutic solutions

Ensuring worldwide access to quality products and healthcare is paramount.

To achieve this goal, we at Sorin Group reinforce the delivery of our technologies in established markets such as Western Europe and the US, and strive to improve access in emerging markets such as China, Brazil, and Russia.

Across the globe, we continue to identify talents and invest in novel start-up companies that are working to provide novel therapeutic answers to unmet clinical needs.

Recognition and awards

At Sorin Group we are proud that our products help people all over the world to live better day by day. Our employees work hard to make a difference.
We are honored when organizations recognize us for our innovation, business practices and people. Here is a sample of the recent awards and recognition we have recently received:


July -  Sorin Group receives the ‘Compliance Award’ in Italy  - Sorin Group  is recognized as having the ‘Best Compliance Program’ by Top Legal Corporate Counsel Awards.

It is the first time that this award has been won twice by the same Company. Sorin Group was particularly complimented for having “… implemented a strong and effective compliance program that has been internationally recognized for its innovative nature, and the value it adds to the company”.

February -  Sorin Group wins the Business Compliance Award 231 for its unique and highly regarded compliance program and creative compliance solutions approach to business ethics.


October - Sorin Group becomes the 1st company in Europe to Meet FDA’s Unique Device Identifier (UDI) requirements. The UDI system established by the U.S. Food and Drug Administration aims to adequately identify medical devices through their distribution and use to improve patient safety, modernize device post-market surveillance, and facilitate medical device innovation.

In addition, Sorin receives the "Innovation Partner of the Year” award by Oracle for exhibiting the highest level of innovation in driving business process and system improvements.

July  -  Sorin Group is  granted the 2014 ‘3D InCites’ Award in the ‘Devices’ category during the SEMICON West 2014 Convention (Phoenix, Arizona).

The prestigious ‘3DInCites’ award honors Sorin for successfully manufacturing 3D heterogeneous integrated modules in a pilot line. Today all active medical devices (cardiac, neurological or cochlear implants) need 3D heterogeneous integration to reduce the size of the electronics they contain.

June - KORA 100 pacemaker and its  ‘Automatic MRI Mode’ receives ‘Cardiostim InnovationAward in the Practice Improvement Category.

Cardiostim, a worldwide scientific congress in the field of electrophysiology and cardiac techniques, gathered some 5,629 attendees, including the most distinguished ones from all over the world.

March - André-Michel Ballester (CEO Sorin Group) is elected to the Board of Advamed, the US Association of Medical Device Manufacturers.


July -  Sorin Group receives the ‘Compliance Award’ in Italy  - Sorin Group  is recognized as having the ‘Best Compliance Program’ by Top Legal Corporate Counsel Awards.

The jury praised our unique compliance program, the manner in which we achieve substantive results, and our formal adherence to the rules governing our industry.

May - Sorin Group is granted  ‘Best international investor in France’ by Minister of Industrial Renewal, Arnaud Montebourg. This award is granted to international innovative companies manufacturing high added value products that have R&D and manufacturing operations in France.

Version unknown | Revision 110937 | Status unstable | SessionId 0BEB3ABB00B60D066942EF87E603D561.jvm1